Myopenia

1 paper2 findings

Humans1

Associations

1

PhenoAgeAccel

upin humans1HR 1.21

1 study

PhenoAgeAccel raises the risk of myopenia in humans (HR 1.21, 95% CI 1.08-1.35).
“PhenoAgeAccel was associated with increased risk of incident myopenia (HR 1.21, 95% CI 1.08-1.35)”
Humans4.1 yearsn = 61,669
Association of biological age acceleration with muscle aging phenotype in young and middle-aged adults: a prospective cohort study
GeroScience15 Jul 2026
PhenoAgeAccel is associated with myopenia in humans (OR 1.16, 95% CI 1.08-1.25).
“PhenoAgeAccel was associated with higher odds of myopenia (OR 1.16, 95% CI 1.08-1.25)”
Humansn = 165,015
Association of biological age acceleration with muscle aging phenotype in young and middle-aged adults: a prospective cohort study
GeroScience15 Jul 2026

More on PhenoAgeAccel

Latest

1 in 12 months

GeroScience15 Jul

Association of biological age acceleration with muscle aging phenotype in young and middle-aged adults: a prospective cohort study

Cohort study of 165,015 peopleBiomarkers

Cancer Medicine10 Apr

Accelerated epigenetic aging and myopenia in young adult cancer survivors

Study in peopleBiomarkers